Table 2.

Summary of the correlation of TRIP13 expression and clinical outcomes.

Tumor	The correlation of TRIP13 expression and OS	P Value
Adrenocortical carcinoma	Negative	1 * 10−8
Breast invasive carcinoma	NS	0.11
Cervical squamous cell carcinoma and endocervical adenocarcinoma	NS	0.69
Cholangio carcinoma	NS	0.6
Colon adenocarcinoma	NS	0.18
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	NS	0.71
Esophageal carcinoma	NS	0.9
Glioblastoma multiforme	NS	0.24
Head and Neck squamous cell carcinoma	NS	0.94
Kidney Chromophobe	Negative	0.012
Kidney renal clear cell carcinoma	Negative	0.0085
Kidney renal papillary cell carcinoma	Negative	0.00015
Acute Myeloid Leukemia	NS	0.24
Brain lower grade Glioma	Negative	2.9 * 10−5
Liver hepatocellular carcinoma	Negative	2 * 10−4
Lung adenocarcinoma	Negative	0.001
Lung squamous cell carcinoma	NS	0.46
Mesothelioma	Negative	1.3 * 10−6
Ovarian serous cystadenocarcinoma	Negative	0.0076
Pancreatic adenocarcinoma	Negative	0.04
Pheochromocytoma and Paraganglioma	NS	0.17
Prostate adenocarcinoma	NS	0.74
Rectum adenocarcinoma	NS	0.94
Sarcoma	NS	0.063
Skin Cutaneous Melanoma	Negative	0.036
Stomach adenocarcinoma	NS	0.99
Testicular Germ Cell Tumors	NS	0.33
Thyroid carcinoma	NS	0.36
Thymoma	Negative	0.048
Uterine Corpus Endometrial Carcinoma	NS	0.75
Uterine Carcinosarcoma	NS	0.73
Uveal Melanoma	NS	0.55